Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peterson, J.
Right arrow Articles by Schiff, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peterson, J.
Right arrow Articles by Schiff, S.
American Journal of Hospital Pharmacy, Vol 48, Issue 9, 1962-1964
Copyright © 1991 by American Society of Health-System Pharmacists

Articles

Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs

JP Peterson, VJ Colucci, and SE Schiff


The impact on drug therapy and costs of a program to identify and correct unadjusted dosage in renally impaired patients is described. The program was instituted in May 1988 by the clinical pharmacy staff at a 272-bed hospital. Each day the clinical pharmacist uses laboratory data to list patients with serum creatinine concentrations greater than 1.5 mg/dL. The pharmacist screens the pharmacy profiles of listed patients and calculates creatinine clearance for patients receiving renally eliminated drugs. If, after reviewing the patient's medical record, the pharmacist judges that a dosage adjustment may be appropriate, he writes a confidential note to the physician. From May 1988 through June 1989, 2341 patients with elevated serum creatinine were monitored. During that period, 162 notes were left; recommendations from 142 (88%) of the notes were accepted by physicians. Most of the notes were written for patients receiving antimicrobials or histamine H2-receptor antagonists. The program, which requires 20-30 minutes of pharmacist time per day, avoided $5003 in drug acquisition costs and cost $2700 to administer during the one-year period. When the costs associated with drug preparation and administration are considered, net cost avoidance was $5040. An intervention program in which notes to physicians are written when patients with abnormal serum creatinine values are receiving drugs for which a dosage adjustment appears indicated (1) has medical staff acceptance, (2) helps to satisfy standards of the Joint Commission on Accreditation of Healthcare Organizations, and (3) saves money.
 



This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
J. Manlucu, M. Tonelli, J. G. Ray, A. Papaioannou, G. Youssef, H. R. Thiessen-Philbrook, A. Holbrook, and A. X. Garg
Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence
Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2376 - 2384.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
C. L Long, M. A Raebel, D. W Price, and D. J Magid
Compliance with Dosing Guidelines in Patients with Chronic Kidney Disease
Ann. Pharmacother., May 1, 2004; 38(5): 853 - 858.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
L. SALOMON, G. DERAY, M. C. JAUDON, C. CHEBASSIER, P. BOSSI, V. LAUNAY-VACHER, B. DIQUET, J. M. CEZA, S. LEVU, G. BRUCKER, et al.
Medication misuse in hospitalized patients with renal impairment
Int. J. Qual. Health Care, August 1, 2003; 15(4): 331 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
L. SALOMON, S. LEVU, G. DERAY, V. LAUNAY-VACHER, G. BRUCKER, and P. RAVAUD
Assessing residents' prescribing behavior in renal impairment
Int. J. Qual. Health Care, May 1, 2003; 15(3): 235 - 240.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society of Health-System Pharmacists.